M. Reichman

Journal of Clinical Oncology · 2007–2015

A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from M. Reichman's perspective

Ordered by how strongly the researchers M. Reichman trusts endorse each paper. Same corpus, a different order for every researcher.

1. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities… (American Journal of Epidemiology)
2. Diagnosis and treatment of hepatocellular carcinoma. (Gastroenterology)
3. SEER Cancer Statistics Review, 1975-2003
4. Molecular Targeted Therapies in Hepatocellular Carcinoma (Hepatology)
5. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups (Cancer Causes and Control)
6. International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising (International Journal of Cancer)
7. Hepatocellular carcinoma (The Lancet)
8. Validating Administrative Data in Stroke Research (Stroke)
9. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. (Gastroenterology)
10. Globocan 2000 : cancer incidence, mortality and prevalence worldwide

Their papers

• Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation (2015) — 656 citations
• Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. (2009) — 1,736 citations
• Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study (2008) — 802 citations
• Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. (2007) — 1,095 citations